Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.

[1]  S. Solomon,et al.  Heart failure with mid‐range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum , 2018, European journal of heart failure.

[2]  R. A. Agra Bermejo,et al.  Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry. , 2018, Cardiology journal.

[3]  G. Filippatos,et al.  Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology , 2018, European journal of heart failure.

[4]  Nicola Orsini,et al.  Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEF. , 2018, JACC. Heart failure.

[5]  L. Lund,et al.  Is ejection fraction in heart failure a limitation or an opportunity? , 2018, European journal of heart failure.

[6]  M. de Antonio,et al.  Recovered heart failure with reduced ejection fraction and outcomes: a prospective study , 2017, European journal of heart failure.

[7]  T. Shiroto,et al.  Characterization of heart failure patients with mid‐range left ventricular ejection fraction—a report from the CHART‐2 Study , 2017, European journal of heart failure.

[8]  L. Lund,et al.  Association between enrolment in a heart failure quality registry and subsequent mortality—a nationwide cohort study , 2017, European journal of heart failure.

[9]  L. Lund,et al.  Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study , 2017, Circulation. Heart failure.

[10]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[11]  J. Butler,et al.  Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction. , 2016, JAMA cardiology.

[12]  C. Lam,et al.  Understanding Heart Failure With Mid-Range Ejection Fraction. , 2016, JACC. Heart failure.

[13]  B. French,et al.  Heart Failure With Recovered Ejection Fraction: Clinical Description, Biomarkers, and Outcomes , 2014, Circulation.

[14]  J. G. González Juanatey,et al.  Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry. , 2013, Cardiology journal.

[15]  Shannon M. Dunlay,et al.  Longitudinal Changes in Ejection Fraction in Heart Failure Patients With Preserved and Reduced Ejection Fraction , 2012, Circulation. Heart failure.

[16]  C. Ayers,et al.  The natural history of new-onset heart failure with a severely depressed left ventricular ejection fraction: implications for timing of implantable cardioverter-defibrillator implantation. , 2012, American heart journal.

[17]  Akshay S. Desai,et al.  Heart failure with recovered ejection fraction: a distinct clinical entity. , 2011, Journal of cardiac failure.

[18]  J. Ludvigsson,et al.  External review and validation of the Swedish national inpatient register , 2011, BMC public health.

[19]  Marco Merlo,et al.  Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. , 2011, Journal of the American College of Cardiology.

[20]  F. Crea,et al.  Sex-related differences in myocardial remodeling. , 2010, Journal of the American College of Cardiology.

[21]  U. Dahlström,et al.  Heart failure registry: a valuable tool for improving the management of patients with heart failure , 2010, European journal of heart failure.

[22]  Thomas H. Marwick,et al.  Prediction of All-Cause Mortality From Global Longitudinal Speckle Strain: Comparison With Ejection Fraction and Wall Motion Scoring , 2009, Circulation. Cardiovascular imaging.

[23]  Dong-Jin Oh,et al.  Global 2-dimensional strain as a new prognosticator in patients with heart failure. , 2009, Journal of the American College of Cardiology.

[24]  Karl Swedberg,et al.  Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients , 2005, Circulation.

[25]  E. Ingelsson,et al.  The validity of a diagnosis of heart failure in a hospital discharge register , 2005, European journal of heart failure.

[26]  S. Solomon,et al.  Changes in Ventricular Size and Function in Patients Treated With Valsartan, Captopril, or Both After Myocardial Infarction , 2005, Circulation.

[27]  L. Tarantini,et al.  Chronic left ventricular failure in the community: Prevalence, prognosis, and predictors of the complete clinical recovery with return of cardiac size and function to normal in patients undergoing optimal therapy. , 2004, Journal of cardiac failure.

[28]  M. Metra,et al.  Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance. , 2003, American heart journal.

[29]  I. Shapira,et al.  The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. , 2000, Journal of the American College of Cardiology.

[30]  A. Rigby,et al.  Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials , 2018, European heart journal.

[31]  Volkmar Falk,et al.  2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.

[32]  C. O'connor,et al.  Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF. , 2012, American heart journal.

[33]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[34]  P. Binkley,et al.  Recovery of normal ventricular function in patients with dilated cardiomyopathy: predictors of an increasingly prevalent clinical event. , 2008, American heart journal.

[35]  C. Visser,et al.  Ejection fraction improvement by beta-blocker treatment in patients with heart failure: an analysis of studies published in the literature. , 1998, Journal of cardiovascular pharmacology.